Skip to main content

Commit To Purchase Coherus BioSciences At $1, Earn 20% Using Options

Investors considering a purchase of Coherus BioSciences Inc (CHRS) stock, but tentative about paying the going market price of $1.28/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2026 put at the $1 strike, which has a bid at the time of this writing of 20 cents..
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.